Literature DB >> 24460676

Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

I Azimi1, S J Roberts-Thomson, G R Monteith.   

Abstract

Ca(2+) influx through Ca(2+) permeable ion channels is a key trigger and regulator of a diverse set of cellular events, such as neurotransmitter release and muscle contraction. Ca(2+) influx is also a regulator of processes relevant to cancer, including cellular proliferation and migration. This review focuses on calcium influx in breast cancer cells as well as the potential for pharmacological modulators of specific Ca(2+) influx channels to represent future agents for breast cancer therapy. Altered expression of specific calcium permeable ion channels is present in some breast cancers. In some cases, such changes can be related to breast cancer subtype and even prognosis. In vitro and in vivo models have now helped identify specific Ca(2+) channels that play important roles in the proliferation and invasiveness of breast cancer cells. However, some aspects of our understanding of Ca(2+) influx in breast cancer still require further study. These include identifying the mechanisms responsible for altered expression and the most effective therapeutic strategy to target breast cancer cells through specific Ca(2+) channels. The role of Ca(2+) influx in processes beyond breast cancer cell proliferation and migration should become the focus of studies in the next decade.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  breast cancer; calcium channels; calcium influx; calcium signalling; oncology

Mesh:

Substances:

Year:  2014        PMID: 24460676      PMCID: PMC3925034          DOI: 10.1111/bph.12486

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  165 in total

1.  Nomenclature of voltage-gated calcium channels.

Authors:  E A Ertel; K P Campbell; M M Harpold; F Hofmann; Y Mori; E Perez-Reyes; A Schwartz; T P Snutch; T Tanabe; L Birnbaumer; R W Tsien; W A Catterall
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

2.  Counting functional inositol 1,4,5-trisphosphate receptors into the plasma membrane.

Authors:  Olivier Dellis; Ana M Rossi; Skarlatos G Dedos; Colin W Taylor
Journal:  J Biol Chem       Date:  2007-11-13       Impact factor: 5.157

Review 3.  Voltage-gated calcium channels and disease.

Authors:  Stuart M Cain; Terrance P Snutch
Journal:  Biofactors       Date:  2011 May-Jun       Impact factor: 6.113

4.  Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis.

Authors:  Rajender K Motiani; Xuexin Zhang; Kelly E Harmon; Rebecca S Keller; Khalid Matrougui; James A Bennett; Mohamed Trebak
Journal:  FASEB J       Date:  2012-09-19       Impact factor: 5.191

Review 5.  Calcium secretion into milk.

Authors:  Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-04       Impact factor: 2.673

6.  Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse.

Authors:  J M Taylor; R U Simpson
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

7.  Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.

Authors:  Kristina Leuner; Victor Kazanski; Margarethe Müller; Kirill Essin; Bettina Henke; Maik Gollasch; Christian Harteneck; Walter E Müller
Journal:  FASEB J       Date:  2007-07-31       Impact factor: 5.191

8.  Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function.

Authors:  Gabriel Bidaux; Matthieu Flourakis; Stéphanie Thebault; Alexander Zholos; Benjamin Beck; Dimitra Gkika; Morad Roudbaraki; Jean-Louis Bonnal; Brigitte Mauroy; Yaroslav Shuba; Roman Skryma; Natalia Prevarskaya
Journal:  J Clin Invest       Date:  2007-05-17       Impact factor: 14.808

9.  Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.

Authors:  Thomas Fixemer; Ulrich Wissenbach; Veit Flockerzi; Helmut Bonkhoff
Journal:  Oncogene       Date:  2003-10-30       Impact factor: 9.867

10.  Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

Authors:  J Baselga; L Norton; J Albanell; Y M Kim; J Mendelsohn
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

View more
  61 in total

1.  The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.

Authors:  Charlotte K Y Ng; Salvatore Piscuoglio; Felipe C Geyer; Kathleen A Burke; Fresia Pareja; Carey A Eberle; Raymond S Lim; Rachael Natrajan; Nadeem Riaz; Odette Mariani; Larry Norton; Anne Vincent-Salomon; Y Hannah Wen; Britta Weigelt; Jorge S Reis-Filho
Journal:  Clin Cancer Res       Date:  2017-02-02       Impact factor: 12.531

Review 2.  The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting.

Authors:  Sarah J Roberts-Thomson; Silke B Chalmers; Gregory R Monteith
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 3.  The calcium-cancer signalling nexus.

Authors:  Gregory R Monteith; Natalia Prevarskaya; Sarah J Roberts-Thomson
Journal:  Nat Rev Cancer       Date:  2017-04-07       Impact factor: 60.716

4.  Immune response pathways enriched in breast cancer samples with brain metastasis.

Authors:  Peng Wang; Zengfeng Sun; Zhen Zhang; Qiang Yin
Journal:  Gland Surg       Date:  2021-12

5.  Targetable T-type Calcium Channels Drive Glioblastoma.

Authors:  Ying Zhang; Nichola Cruickshanks; Fang Yuan; Baomin Wang; Mary Pahuski; Julia Wulfkuhle; Isela Gallagher; Alexander F Koeppel; Sarah Hatef; Christopher Papanicolas; Jeongwu Lee; Eli E Bar; David Schiff; Stephen D Turner; Emanuel F Petricoin; Lloyd S Gray; Roger Abounader
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

6.  A new correlation clustering method for cancer mutation analysis.

Authors:  Jack P Hou; Amin Emad; Gregory J Puleo; Jian Ma; Olgica Milenkovic
Journal:  Bioinformatics       Date:  2016-08-18       Impact factor: 6.937

7.  Subtype specific targeting of calcium signaling in breast cancer.

Authors:  Monish Ram Makena; Rajini Rao
Journal:  Cell Calcium       Date:  2019-11-12       Impact factor: 6.817

8.  Esculetin, a natural coumarin compound, evokes Ca(2+) movement and activation of Ca(2+)-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells.

Authors:  Hong-Tai Chang; Chiang-Ting Chou; You-Sheng Lin; Pochuen Shieh; Daih-Huang Kuo; Chung-Ren Jan; Wei-Zhe Liang
Journal:  Tumour Biol       Date:  2015-10-28

9.  Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma.

Authors:  Stephanie C Melkonian; Carrie R Daniel; Yuanqing Ye; Nizar M Tannir; Jose A Karam; Surena F Matin; Christopher G Wood; Xifeng Wu
Journal:  Cancer       Date:  2015-11-09       Impact factor: 6.860

10.  Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines.

Authors:  Cristina Pierro; Xuexin Zhang; Cynthia Kankeu; Mohamed Trebak; Martin D Bootman; H Llewelyn Roderick
Journal:  Cell Calcium       Date:  2018-03-14       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.